Haematological malignancies
Clinical research includes relapsed or refractory CD20+ diffuse large B-cell lymphoma, mantle cell lymphoma, and indolent lymphoma, with interest in B-cell lymphoma treatment and cellular immunotherapy.
- CD20+ diffuse large B-cell lymphoma
- mantle cell lymphoma
- indolent lymphoma
- CAR T-cell therapy
The oncology portfolio reflects work in advanced lymphoid cancers and immune-based treatment strategies.
Autoimmune and inflammatory disease
Research activity spans rheumatoid arthritis, systemic lupus erythematosus, myositis, psoriatic arthritis, and inflammatory bowel disease, covering both systemic and organ-specific immune-mediated disorders.
- rheumatoid arthritis
- systemic lupus erythematosus
- myositis
- psoriatic arthritis
- inflammatory bowel disease
These studies align with therapeutic interest in immune dysregulation and chronic inflammatory disease.
Maternal and infant pharmacology
Trials examine the transfer of prednisolone and metformin into breast milk and infant plasma, with attention to medication exposure during lactation and early infancy.
- prednisolone
- metformin
- breast milk transfer
- breastfed infants
The research focus includes drug distribution in breastfeeding dyads and treatment safety in postpartum care.
Infectious disease and diabetes care
Additional studies involve febrile urinary tract infection caused by Escherichia coli and metabolic disease research in type 2 diabetes mellitus and gestational diabetes mellitus.
- febrile urinary tract infection
- Escherichia coli
- type 2 diabetes mellitus
- gestational diabetes mellitus
These areas connect antimicrobial treatment questions with ongoing work in glycaemic disease management.
